Citation Impact
Citing Papers
Omalizumab for asthma in adults and children
2014
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation
2005
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
2004
Targeting the NF-κB pathway in asthma and chronic obstructive pulmonary disease
2008
Randomized Controlled Trial of Oral Antifungal Treatment for Severe Asthma with Fungal Sensitization
2008
FCER2: A pharmacogenetic basis for severe exacerbations in children with asthma
2007
Update on optimal use of omalizumab in management of asthma
2011
IgE and mast cells in allergic disease
2012 Standout
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
2011
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
Asthma
2017 Standout
Omalizumab for the Treatment of Inadequately Controlled Allergic Rhinitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
2014
The development of allergic inflammation
2008 StandoutNature
mRNA transcript therapy
2014 StandoutNobel
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Current status of therapy with omalizumab in children
2014
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
2012 Standout
Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving Omalizumab (Xolair) therapy
2005
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
2011
Allergic rhinitis: An update on disease, present treatments and future prospects
2011
Accuracy of US Food and Drug Administration–cleared IgE antibody assays in the presence of anti-IgE (omalizumab)
2006
IgE, mast cells, basophils, and eosinophils
2010 Standout
Anti‐immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti‐inflammatory activity and clinical efficacy
2005
Exploring the Effects of Omalizumab in Allergic Asthma
2013
Effects of Treatment with Anti-immunoglobulin E Antibody Omalizumab on Airway Inflammation in Allergic Asthma
2004
Omalizumab for the treatment of severe persistent allergic asthma
2009
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Population Change and the Genesis of Commonfields on a Norfolk Manor
1980
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Design, Synthesis, and Inhibitory Activity of Potent, Photoswitchable Mast Cell Activation Inhibitors
2013 StandoutNobel
Omalizumab Reverses the Phenotypic and Functional Effects of IgE-Enhanced FcεRI on Human Skin Mast Cells
2007
British Economic Growth, 1270–1870
2014 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
Omalizumab for treatment of allergic rhinitis
2013
Works of Howard Fox being referenced
Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma
2003
Predicting Response to Omalizumab, an Anti-IgE Antibody, in Patients With Allergic Asthma
2004
Improvement in quality of life with omalizumab in patients with severe allergic asthma
2006
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis
2003
Efficacy of Omalizumab, an Anti-immunoglobulin E Antibody, in Patients with Allergic Asthma at High Risk of Serious Asthma-related Morbidity and Mortality
2001
Omalizumab, an Anti-IgE Antibody, Provides Parallel Improvements in Symptoms of Allergic Asthma and Perennial Allergic Rhinitis in Patients With Both Diseases: The SOLAR Stud
2003
Inhaled corticosteroid dose-reducing effect of omalizumab in patients with controlled, severe asthma according to usage of inhaled long-acting beta-agonists
2002
The Chronology of Enclosure and Economic Development in Medieval Devon
1975